Protein therapeutics has made much progress over the past 20 years. Protein therapeutics, including vaccines, monoclonal antibodies, recombinant proteins, and peptides, are highly successful in clinical and currently enjoy unprecedented recognition of their potential. There are some advantages of protein therapeutics, including highly specific and complex functions that cannot be replaced by small-molecule drugs, no gene therapy risks, shorter duration of clinical development for the Food and Drug Administration (FDA) approval, etc.
For now, biological drugs have been widely used in treatment and prevention of disease. In order to make sure the protein therapeutics are correctly synthesized and modified, and maintain correct senior structures, the quality of biological drugs needs to be accessed and protein therapeutics quality control presents a challenge for the biopharma market.
Protein Therapeutics Quality Control Analysis at Creative Proteomics
Creative Proteomics has a high-resolution protein analysis platform to provide comprehensive analysis services for proteins therapeutics. We follow the principles of analysis on the ICH Q6B guidelines of technical requirements for biological products. With years of experience, Creative Proteomics can provide a variety of protein therapeutics quality control analysis services, including but not limited to:
Creative Proteomics prides itself on its intensive experience in protein therapeutic quality control analysis, and we are able to provide you with the highest degree of reliability. Creative Proteomics wants to be your preferred partner to solve complex problems about protein therapeutic quality control analysis.